NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight the significance of Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate Hydrochloride, a key intermediate in the complex synthesis of Erlotinib. This compound, identified by its CAS number 183322-17-0, is fundamental to the production of one of the leading targeted therapies for certain types of cancer, particularly non-small cell lung cancer.

Erlotinib hydrochloride is a potent Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor. The development of such targeted therapies relies heavily on the availability of high-purity, well-characterized chemical intermediates. Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate hydrochloride is one such critical building block. Its precise molecular structure (C15H24ClNO6) and consistent quality ensure that the subsequent synthesis steps can proceed efficiently, leading to a final pharmaceutical product that meets rigorous global standards.

The synthesis of complex pharmaceutical molecules like Erlotinib involves multiple stages, each requiring specific chemical precursors. Our commitment at NINGBO INNO PHARMCHEM CO.,LTD. is to provide reliable access to these essential pharmaceutical intermediates. By focusing on quality and purity, we support drug manufacturers in their quest to produce life-saving medications. The consistent supply of this Erlotinib synthesis chemical is paramount for maintaining the production of this vital oncology drug.

Researchers and manufacturers looking to understand the detailed CAS 183322-17-0 chemical properties will find that this intermediate possesses the necessary functional groups and structural integrity required for the downstream reactions. Its role in the EGFR inhibitor intermediate synthesis pathway is well-established, making it a sought-after compound in the pharmaceutical research and development sector. For those needing to buy ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate hydrochloride, NINGBO INNO PHARMCHEM CO.,LTD. offers a dependable source.

The importance of this compound extends beyond its direct use in Erlotinib. It exemplifies the intricate network of chemical synthesis that underpins modern medicine. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to facilitating advancements in healthcare by ensuring the availability of high-quality API intermediates, contributing to the development of more effective and safer treatments for patients worldwide.

In summary, Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate Hydrochloride is more than just a chemical; it is an enabler of critical cancer therapies. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being a reliable partner in this vital supply chain, providing the foundational chemicals that drive pharmaceutical innovation.